Corporate
Corcept Crashes 50% After FDA Rejects Relacorilant for Cushing's Syndrome
Jan 1
You're signed outSign in or to get full access.
CORCEPT THERAPEUTICS (CORT) Earnings Call Transcripts
Browse quarterly earnings call transcripts for CORCEPT THERAPEUTICS.
Q3 2025
Nov 4, 2025
Q2 2025
Jul 31, 2025
Q1 2025
May 5, 2025
Q4 2024
Feb 26, 2025
Q3 2024
Oct 30, 2024
Q3 2021
Nov 3, 2021
Q2 2021
Jul 29, 2021
Q1 2021
May 6, 2021
Q4 2020
Feb 8, 2021
Q2 2020
Aug 4, 2020
Q1 2020
May 4, 2020